Is Surging AI Connectivity Demand From Amazon and Anthropic Altering The Investment Case For Astera Labs (ALAB)?

• In April 2026, Astera Labs reported very large year-over-year revenue growth in its AI data center connectivity business, supported by institutional buying and growing demand from hyperscalers for its Intelligent Connectivity Platform.
• The company’s role in enabling AI infrastructure for customers such as Amazon and Anthropic highlights how specialized connectivity chips are becoming central to large-scale AI deployments.
• We’ll now examine how Astera Labs’ expanding AI data center connectivity demand, particularly around the Amazon–Anthropic partnership, shapes its existing investment narrative.

Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

Astera Labs Investment Narrative Recap

To own Astera Labs, you need to believe AI data center spending remains strong enough that demand for its connectivity chips keeps building, especially from hyperscalers. The Amazon Anthropic capacity deal and related Trainium demand reinforce the key near term catalyst of AI server buildouts, but also sharpen the biggest risk: Astera’s dependence on a small set of powerful customers whose capex or supplier choices could shift quickly.

Among recent developments, the ratification of the UALink 2.0 specifications in early April looks particularly relevant. By helping formalize open, multi vendor AI interconnect standards that its products already target, UALink ties directly into Astera’s catalyst of broader adoption across PCIe, CXL, Ethernet, and UALink, while also intersecting with the risk that competing standards or integrated solutions could erode its differentiation if the industry’s technical direction changes.

Yet while demand today looks strong, investors should also be aware that a sudden change in hyperscaler AI capex could...

Read the full narrative on Astera Labs (it's free!)

Astera Labs' narrative projects $1.5 billion revenue and $393.5 million earnings by 2028. This requires 34.1% yearly revenue growth and about a $293 million earnings increase from $100.2 million today.

Uncover how Astera Labs' forecasts yield a $204.47 fair value, a 5% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already cautious, assuming revenue of about US$2.0 billion and earnings near US$439 million by 2029, which is far less enthusiastic than consensus, and their concerns about hyperscalers potentially shifting to in house or rival connectivity solutions highlight how differently you and other investors might see the same Amazon Anthropics driven demand, especially if these new developments eventually reshape those forecasts.

Explore 16 other fair value estimates on Astera Labs - why the stock might be worth less than half the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Astera Labs research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Astera Labs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Astera Labs' overall financial health at a glance.

Curious About Other Options?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com